share_log

BioXcel Therapeutics | 8-K: BioXcel Therapeutics Reports Financial Results for the Fourth Quarter and Full Year 2023

SEC announcement ·  Mar 12 07:17
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more